-
Anglický jazyk
Mutation-specific therapies in cystic fibrosis
Autor: Burkhard Tümmler
Cystic fibrosis is a severe ion channel disease of autosomal recessive inheritance that is caused by mutations in the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) gene. Thanks to continuously improved symptomatic treatment during the last five... Viac o knihe
1 kus - skladom u vydavateľa Posielame do 7-10 dní
41.49 €
bežná cena: 46.10 €
O knihe
Cystic fibrosis is a severe ion channel disease of autosomal recessive inheritance that is caused by mutations in the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) gene. Thanks to continuously improved symptomatic treatment during the last five decades this lethal paediatric disease has been transformed into a chronic disorder with a median life expectancy of nowadays more than 50 years. This 2nd edition provides the reader with the background and on-going preclinical and clinical research for the development of mutation-type specific therapy of cystic fibrosis. Starting with the biology and biomarkers of CFTR in the context of cystic fibrosis, the reader gets insight into the basic and clinical research of CFTR modulators from bench to bedside. A large section of the book focuses on the clinical trials, post-approval observational studies and the real-world experience with the CFTR modulators.
- Vydavateľstvo: Uni-Med Verlag AG
- Rok vydania: 2022
- Formát: Hardback
- Rozmer: 244 x 172 mm
- Jazyk: Anglický jazyk
- ISBN: 9783837416305
